BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011

Nov 3, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-11-01

Reporting Person: Cooper Jeffrey H (SVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-10-31	Common Stock	A	228	$13.226	Acquired	40104	Direct
2011-11-01	Common Stock	M	2500	$14.39	Disposed	42604	Direct
2011-11-01	Common Stock	S	2500	$33.258	Disposed	40104	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-11-01	Stock Option (right to buy)	$14.39	M	2500	Disposed	2019-05-11	Common Stock (2500)	Direct

Footnotes

F1: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of April 29, 2011 to October 31, 2011.

F2: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on March 7, 2011.

F3: Original option grant vested 6/48ths on November 12, 2009 and 1/48th on the 12th of every month thereafter.